Portal de Periódicos da CAPES

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs

2020; Elsevier BV; Volume: 8; Issue: 9 Linguagem: Inglês

10.1016/j.jaip.2020.08.006

2213-2201

Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine M. Biggs, Kimberly G. Blumenthal, Patrick J. Brennan, Rebecca G. Breslow, Knut Brockow, Kathleen M. Buchheit, Katherine N. Cahill, Josefina Cernadas, Anca Mirela Chiriac, Elena Crestani, P. Démoly, Pascale Dewachter, Meredith A. Dilley, Jocelyn R. Farmer, Dinah Foer, Ari J. Fried, Sarah L. Garon, Matthew P. Giannetti, David L. Hepner, David I. Hong, Joyce T. Hsu, Parul H. Kothari, Timothy Kyin, Timothy Lax, Min Jung Lee, Kathleen Lee‐Sarwar, Anne Liu, Stephanie Logsdon, Margee Louisias, Andrew J. MacGinnitie, Michelle C. Maciag, Samantha Minnicozzi, Allison E. Norton, Iris M. Otani, Miguel Park, Sarita U. Patil, Elizabeth J. Phillips, Matthieu Picard, Craig D. Platt, Rima Rachid, Tito Rodriguez, Antonino Romano, Cosby A. Stone, Marı́a José Torres, Miriam Verdú, Alberta L. Wang, Paige G. Wickner, Anna R. Wolfson, Johnson T. Wong, Christina Yee, Joseph Zhou, Mariana Castells,

Food Allergy and Anaphylaxis Research

Allergists and clinical immunologists around the world are increasingly faced with the task of addressing drug allergy and hypersensitivity due to the increase in drug reactions. Furthermore, this is often required to maintain patients on first-line therapies, including antibiotics for those with cystic fibrosis, chemotherapeutic agents for those with cancer, and mAbs for patients with chronic inflammatory diseases. The endeavor assumes minor risks such as urticaria and major risks that include anaphylaxis and Stevens-Johnson syndrome.